Search results for: physical function

Science from our Sisters

Norra MacReady | November 1, 2006

Recommended reading from A&R and AC&R

Rheuminations: A Long Journey Brings Unexpected Insights

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS | December 11, 2025

Dr. Kumar links a traffic-jammed drive to healthcare challenges, exploring privilege, advocacy & resilience in this Rheuminations essay.

Peripheral Neuropathy Common Among Patients with Sjögren’s Disease

Vanessa Caceres | November 18, 2025

At this ACR Convergence session, experts discussed the peripheral nervous system involvement with Sjögren’s disease that can have several manifestations.

Complicated Cases Discussed in Pediatric Thieves Market

Thomas R. Collins | November 14, 2025

At this ACR Convergence 2025 session, clinicians discussed complex and difficult-to-diagnose pediatric cases.

3 AC&R Study Summaries: RA & Frailty, Hydroxychloroquine Can Protect Kidneys in Lupus Nephritis, & PT for Knee OA

Arthritis Care & Research | November 11, 2025

Research on PT for knee OA, HCQ’s protective role in lupus nephritis & the link between RA disease activity & frailty.

As Understanding of Long COVID Deepens, the Search for Therapies Continues

Thomas R. Collins | November 7, 2025

Experts discussed causes of long COVID & potential therapies at this ACR Convergence 2025 session.

Differentiating POTS from Other Conditions

Mary Beth Nierengarten | November 6, 2025

At a ACR Convergence 2025 session, two experts discussed POTS, the importance of considering dysautonomia when making a differential diagnosis & an interdisciplinary approach to treatment.

JIA: The Transition to Adult Care

Ruth Jessen Hickman, MD | November 5, 2025

Experts addressed considerations for how to aid patients with juvenile idiopathic arthritis (JIA) in their transition to adult care, specifically highlighting clinical pearls for those with pediatric uveitis and TMJ arthritis.

Does High-Intensity Interval Training Lower Inflammatory Disease Activity?

Kurt Ullman | November 4, 2025

Experts discuss high-intensity interval training as an underused “disease-modifying drug” for inflammatory diseases. Learn how to safely integrate it into patient treatment plans.